Support Program Overview
NovoCare® provides personalized diabetes management support and information on medicines that may help. Sign up for tips and motivation on leading a healthier life.
Get personalized diabetes support.
About Diabetes
Diabetes is a disorder in which the body has trouble with insulin. Find important information about type 1 and type 2 diabetes, as well as personalized support.
Find information on type 1 and 2 diabetes.
Managing Diabetes
There are many healthy ways to manage your diabetes. You and your diabetes care team can work together to create a treatment plan that matches your lifestyle.
Healthy habits for diabetes management.
All About Type 1
Type 1 diabetes is an autoimmune disorder where the body makes little or no insulin. Find tips and resources that can help you along your treatment journey.
Type 1 diabetes tips and resources.
What is Levemir®?
Levemir® is a long-acting insulin that can be taken once or twice daily to control high blood sugar in adults and children with diabetes.
Same insulin, different pen
Levemir® FlexTouch® will be discontinued as of early February 2023 and replaced by Levemir® FlexPen®, a slightly different type of prefilled pen. If you are currently taking Levemir®, you will notice that your pen looks slightly different when you pick it up from the pharmacy. Be sure to watch the video to learn how to use the FlexPen®.
How to use Levemir® FlexPen®
Watch our step-by-step video on how to use the Levemir® FlexPen® or download the Levemir® FlexPen® quick guide.
Learn about another once-daily, long-acting insulin from Novo Nordisk, Tresiba® (insulin degludec) injection 100 U/mL. Tresiba® provides full 24-hour blood sugar control with powerful A1C reduction
What is Levemir® (insulin detemir) injection 100 U/mL?
Do not share your Levemir® FlexPen® with other people, even if the needle has been changed. Do not share needles or syringes with another person. You may give other people a serious infection or get a serious infection from them.
Do not take Levemir® if:
Before taking Levemir®, tell your health care provider about all your medical conditions including, if you:
Tell your healthcare provider all the medicines you take, including prescription and over-the-counter medicines, vitamins, or herbal supplements. Before you start taking Levemir®, talk to your health care provider about low blood sugar and how to manage it.
Serious side effects can lead to death, including:
Other common side effects include:
Your insulin dose may need to change because of:
Please click here for Levemir® Prescribing Information.
Do not share your Tresiba® FlexTouch® with other people, even if the needle has been changed. Do not share needles or syringes with another person. You may give other people a serious infection, or get a serious infection from them.
Do not take Tresiba® if you:
Before taking Tresiba®, tell your health care provider about all your medical conditions, including if you are:
Talk to your health care provider about low blood sugar and how to manage it.
Tresiba® may cause serious side effects that can be life-threatening, including:
Your insulin dose may need to change because of change in level of physical activity or exercise, increased stress, change in diet, weight gain or loss, or illness.
Get emergency medical help if you have trouble breathing, shortness of breath, fast heartbeat, swelling of your face, tongue, or throat, sweating, extreme drowsiness, dizziness, or confusion.
Please click here for Prescribing Information.
What is Levemir® (insulin detemir) injection 100 U/mL?
Do not share your Levemir® FlexPen® with other people, even if the needle has been changed. Do not share needles or syringes with another person. You may give other people a serious infection or get a serious infection from them.
Do not take Levemir® if:
Before taking Levemir®, tell your health care provider about all your medical conditions including, if you:
Tell your healthcare provider all the medicines you take, including prescription and over-the-counter medicines, vitamins, or herbal supplements. Before you start taking Levemir®, talk to your health care provider about low blood sugar and how to manage it.
Serious side effects can lead to death, including:
Other common side effects include:
Your insulin dose may need to change because of:
Please click here for Levemir® Prescribing Information.
Do not share your Tresiba® FlexTouch® with other people, even if the needle has been changed. Do not share needles or syringes with another person. You may give other people a serious infection, or get a serious infection from them.
Do not take Tresiba® if you:
Before taking Tresiba®, tell your health care provider about all your medical conditions, including if you are:
Talk to your health care provider about low blood sugar and how to manage it.
Tresiba® may cause serious side effects that can be life-threatening, including:
Your insulin dose may need to change because of change in level of physical activity or exercise, increased stress, change in diet, weight gain or loss, or illness.
Get emergency medical help if you have trouble breathing, shortness of breath, fast heartbeat, swelling of your face, tongue, or throat, sweating, extreme drowsiness, dizziness, or confusion.
Please click here for Prescribing Information.
Look up your cost at MyLevemirCost.com.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1‑800-FDA-1088.
If you need assistance with prescription costs, help may be available. Visit www.pparx.org or call 1‑888-4PPA-NOW.
Talk to your health care provider about your diabetes management plan, including diet and exercise.
Tresiba® is a prescription medication.
Levemir® is a prescription medication.
Fiasp® is a prescription medication.
NovoLog® is a prescription medication.
NovoLog® Mix 70/30 is a prescription medication.
Xultophy® 100/3.6 is a prescription medication.
Autocover®, Fiasp®, FlexPen®, FlexTouch®, Levemir®, NovoCare®, NovoFine®, NovoLog®, NovoLog® Mix 70/30, NovoPen Echo®, PenFill®, Tresiba®, and Xultophy® are registered trademarks of Novo Nordisk A/S.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
All other trademarks, registered or unregistered, are the property of their respective owners.
© 2022 Novo Nordisk All rights reserved. US22LV00016 December 2022